Psychedelic DMT Importer Steps Up: DEA Invites Public Input
Published Date: 4/1/2026
Notice
Summary
Sterling Wisconsin, LLC wants to become an official importer of a special controlled substance called 5-Methoxy-N,N-dimethyltryptamine. People who make or import similar drugs can share their thoughts or ask for a hearing by May 1, 2026. This move could shake up the drug import scene and means Sterling is stepping into a big new role soon.
No Economic Impacts Identified for this Document
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-09566, Schedules of Controlled Substances: Placement of CUMYL-PEGACLONE in Schedule I
Starting May 13, 2026, the DEA officially puts CUMYL-PEGACLONE—a chemical often linked to illegal drug use—into Schedule I, the strictest drug category. This means anyone making, selling, or using it faces serious legal rules and penalties. This move helps the U.S. follow international drug laws and keeps communities safer without adding new costs.
2026-08588, Bulk Manufacturer of Controlled Substances Application: Patheon API Inc.
Patheon API Inc. wants to make large amounts of special research drugs like dimethyltryptamine and psilocybin. This affects researchers and companies involved in clinical trials, with a chance to comment or ask for a hearing by July 6, 2026. No money changes are mentioned, but the registration could speed up important drug studies.
2026-08595, Specific Listing for Hexahydrocannabinol, A Currently Controlled Schedule I Substance
The DEA is giving hexahydrocannabinol (HHC) its own official spot on the Schedule I drug list starting May 4, 2026. This means HHC, a synthetic cousin of THC, is clearly controlled as a hallucinogen with a unique code, making rules easier to follow. Anyone making, selling, or using HHC should know it’s officially regulated now, but no new fees or costs are added.
2026-08517, Schedules of Controlled Substances: Placement of 4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I
Starting May 1, 2026, the DEA officially puts four tricky chemicals—4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA—into Schedule I, meaning they’re now illegal to make, sell, or use without special permission. This affects anyone handling these substances, who will face strict rules and possible penalties. The move helps keep dangerous synthetic drugs off the streets and protects public health.
2026-08176, Schedules of Controlled Substances: Rescheduling of Food and Drug Administration Approved Products Containing Marijuana From Schedule I to Schedule III; Corresponding Change to Permit Requirements
Starting April 28, 2026, FDA-approved marijuana-based medicines move from the strictest drug category (Schedule I) to a less strict one (Schedule III). This change helps medical marijuana businesses get faster federal permits to make and sell these products legally. Patients and companies benefit from easier access and clearer rules, while the government keeps control to meet international drug laws.
2026-08177, Schedules of Controlled Substances: Rescheduling of Marijuana
The DEA is planning to move marijuana to Schedule III, which means it’s seen as less risky and easier to access legally. This change affects anyone using, selling, or researching marijuana and kicks off with a public hearing starting June 29, 2026. If you want to join the conversation, you need to sign up by May 28, 2026, so get ready for some big shifts in marijuana rules and opportunities!
Previous / Next Documents
Previous: 2026-06259, Importer of Controlled Substances Application: Indivior Manufacturing LLC
Indivior Manufacturing LLC wants to become an official importer of certain controlled substances, like Thebaine, which are tightly regulated drugs. People and companies involved can share their thoughts or ask for a hearing by May 1, 2026. This move could affect drug supply chains and involves careful government oversight but no direct costs to the public.
Next: 2026-06261, Bulk Manufacturer of Controlled Substances Application: Pharmaron Manufacturing Services (US) LLC
Pharmaron Manufacturing Services (US) LLC wants to make big batches of some strong medicines like oxycodone and thebaine for clinical trials. If you have thoughts or concerns, you can share them online by June 1, 2026. This move affects drug makers and researchers and helps speed up new medicine testing without extra costs right now.